Elutia (ELUT) Income from Continuing Operations (2019 - 2026)
Elutia's (ELUT) quarterly Income from Continuing Operations came in at 7894000.0 in Q1 2026, down 318.34% year-on-year from 3615528.64 in Q1 2025, and down 20.48% quarter-over-quarter from 6552000.0 in Q4 2025.
Elutia (ELUT) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Elutia has disclosed Income from Continuing Operations across 8 years of filings, most recently posting 7894000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 7894000.0, down 318.34% year-over-year; the trailing twelve-month figure through Mar 2026 was 24439000.0 (up 28.25% YoY), and the FY2025 annual result was 15913000.0, up 64.91% from the prior year.
- Income from Continuing Operations came in at 7894000.0 for Q1 2026 at Elutia, down from 6552000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3339000.0 in Q3 2024 to a low of 28360000.0 in Q2 2024.
- The 5-year median for Income from Continuing Operations is 8149000.0 (2022), against an average of 8961117.65.
- Across the five-year window, Income from Continuing Operations jumped 139.19% in 2024 and sank 318.34% in 2026, its largest moves.
- Elutia's Income from Continuing Operations stood at 6015000.0 in 2022, then slumped by 153.07% to 15222000.0 in 2023, then surged by 53.0% to 7155000.0 in 2024, then advanced by 8.43% to 6552000.0 in 2025, then fell by 20.48% to 7894000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 7894000.0 (Q1 2026), 6552000.0 (Q4 2025), and 383000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Elutia | 45.15 Mn | 16.66 Mn | 1.80 Mn | -7.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.89 Mn |
| Dec 31, 2025 | -6.55 Mn |
| Sep 30, 2025 | -383,000.00 |
| Jun 30, 2025 | -9.61 Mn |
| Mar 31, 2025 | -1.89 Mn |
| Dec 31, 2024 | -7.16 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | -28.36 Mn |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | -15.22 Mn |
| Sep 30, 2023 | -8.52 Mn |
| Jun 30, 2023 | -7.73 Mn |
| Mar 31, 2023 | -9.78 Mn |
| Dec 31, 2022 | -6.02 Mn |
| Sep 30, 2022 | -11.03 Mn |
| Jun 30, 2022 | -9.40 Mn |
| Mar 31, 2022 | -8.15 Mn |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -8.32 Mn |
| Jun 30, 2021 | -2.39 Mn |